160 related articles for article (PubMed ID: 33500310)
1. Migration of PFO closure device and entrapment within tricuspid valve leading to tricuspid regurgitation: surgical correction of an extremely rare complication after transcutaneous PFO closure.
Thet MS; Sepehripour A; Atieh AEFA; Di Salvo C
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33500310
[TBL] [Abstract][Full Text] [Related]
2. Impact of percutaneous device implantation for closure of patent foramen ovale on valve insufficiencies.
Wöhrle J; Kochs M; Spiess J; Nusser T; Hombach V; Merkle N
Circulation; 2009 Jun; 119(23):3002-8. PubMed ID: 19487592
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous closure of patent foramen ovale and valvular function -- effect of the amplatzer occluder.
Krasniqi N; Roth J; Siegrist PT; Toggweiler S; Gruner C; Greutmann M; Tanner FC; Lüscher TF; Corti R
J Invasive Cardiol; 2012 Jun; 24(6):274-7. PubMed ID: 22684381
[TBL] [Abstract][Full Text] [Related]
4. Urgent transcatheter closure of patent foramen ovale followed by elective right-sided valve surgery for decompensated carcinoid heart disease.
Hayashi Y; McGaw DJ; Goldstein J
Heart Lung Circ; 2008 Jun; 17(3):259-61. PubMed ID: 17416551
[TBL] [Abstract][Full Text] [Related]
5. Robotic-assisted removal of an Amplatzer atrial septal occluder device for residual shunting, closure of septal defect and simultaneous tricuspid annuloplasty.
Onan B; Kadirogullari E; Guler S; Kahraman Z
J Robot Surg; 2018 Mar; 12(1):185-188. PubMed ID: 28470409
[TBL] [Abstract][Full Text] [Related]
6. Late dislocation of an Amplatzer septal occluder in the chordae tendineae of the tricuspid valve after failed transcatheter closure of atrial septal defect.
Artemiou P; Bezák B; Hulman M
Hellenic J Cardiol; 2019; 60(3):205-206. PubMed ID: 30063983
[No Abstract] [Full Text] [Related]
7. Stepwise Progression of Right-to-Left Atrial Shunting through a Combination of Patent Foramen Ovale and Tricuspid Regurgitation.
Kransdorf EP; Kransdorf LN; Fortuin FD; Sweeney JP; Wilansky S
Tex Heart Inst J; 2016 Apr; 43(2):171-4. PubMed ID: 27127438
[TBL] [Abstract][Full Text] [Related]
8. Clinical Experience of Percutaneous Patent Foramen Ovale Closure Using the Amplatzer PFO Occluder in Japanese Patients to Prevent the Recurrence of Cryptogenic Stroke.
Takafuji H; Obunai K; Makihara Y; Kato N; Watanabe H
Intern Med; 2021 Nov; 60(21):3385-3390. PubMed ID: 34024855
[TBL] [Abstract][Full Text] [Related]
9. Application of Transesophageal Echocardiography in Amplatzer Atrial Septal Defect Occluder for Percutaneous Closure of Large Patent Foramen Ovale.
Du Y; Xie H; Shao H; Cheng G; He L; Wang X; He X; Lan B; Zhang Y; Tian G
Cardiovasc Ther; 2022; 2022():3226080. PubMed ID: 35936794
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
[TBL] [Abstract][Full Text] [Related]
11. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
Aral M; Mullen M
Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of Cardi-O-fix occluder for percutaneous closure of a patent foramen ovale: A single-center prospective study.
Zhao E; Liu W; Zhang Y; Cheng G; Du Y; He L; Wang X; He X
Medicine (Baltimore); 2017 Apr; 96(14):e6572. PubMed ID: 28383438
[TBL] [Abstract][Full Text] [Related]
13. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
[TBL] [Abstract][Full Text] [Related]
14. Patent foramen ovale with complex anatomy: Comparison of two different devices (Amplatzer Septal Occluder device and Amplatzer PFO Occluder device 30/35).
Giordano M; Gaio G; Santoro G; Palladino MT; Sarubbi B; Golino P; Russo MG
Int J Cardiol; 2019 Mar; 279():47-50. PubMed ID: 30344060
[TBL] [Abstract][Full Text] [Related]
15. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
Manolis AS
Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Contrast Echocardiography and Clinical Follow-Up after Percutaneous Closure of Patent Foramen Ovale Using Two Different Atrial Septal Occluder Devices.
Scalise F; Auguadro C; Sorropago G; Sorropago A; Novelli E; Finizio M; Specchia G
J Interv Cardiol; 2016 Aug; 29(4):406-13. PubMed ID: 27338839
[TBL] [Abstract][Full Text] [Related]
17. Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale.
Susuri N; Obeid S; Ulmi M; Siontis GCM; Wahl A; Windecker S; Nietlispach F; Meier B; Praz F
EuroIntervention; 2017 Sep; 13(7):858-866. PubMed ID: 28437244
[TBL] [Abstract][Full Text] [Related]
18. Embolization of patent foramen ovale closure devices: incidence, role of imaging in identification, potential causes, and management.
Goel SS; Aksoy O; Tuzcu EM; Krasuski RA; Kapadia SR
Tex Heart Inst J; 2013; 40(4):439-44. PubMed ID: 24082375
[TBL] [Abstract][Full Text] [Related]
19. Long-term transesophageal echocardiography after patent foramen ovale closure by BioSTAR and Amplatzer patent foramen ovale occluders.
Suligoj NC; Rojko M; Suligoj B; Zorc M; Kar S; Noc M
Catheter Cardiovasc Interv; 2020 Feb; 95(3):349-354. PubMed ID: 31131978
[TBL] [Abstract][Full Text] [Related]
20. Cleft on tricuspid anterior leaflet.
Motoyoshi N; Tofukuji M; Sakurai M; Ohmi M; Tabayashi K
Ann Thorac Surg; 2001 Apr; 71(4):1350-1. PubMed ID: 11308190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]